Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22689129 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study
Condition: Recurrent Prostate Cancer
Interventions: Drug: 3 POMx capsules;   Drug: 1 POMx capsule

Indicates status has not been verified in more than two years